© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 9, 700-704,
May 2, 2001
© 2001 Oxford University Press
REPORT |
p53 Missense Mutations in Microdissected High-Grade Ductal Carcinoma In Situ of the Breast
Affiliations of authors: S. J. Done, M. Redston (Department of Laboratory Medicine and Pathobiology and Samuel Lunenfeld Research Institute), S. Eskandarian (Samuel Lunenfeld Research Institute), S. Bull (Department of Public Health Sciences and Samuel Lunenfeld Research Institute), I. L. Andrulis (Departments of Molecular and Medical Genetics and Laboratory Medicine and Pathobiology and Samuel Lunenfeld Research Institute), Mount Sinai Hospital, Toronto, ON, Canada.
Correspondence to: Irene L. Andrulis, Ph.D., Samuel Lunenfeld Research Institute, Rm. 984, Mount Sinai Hospital, 600 University Ave., Toronto, ON, Canada, M5G 1X5 (e-mail: andrulis{at}mshri.on.ca).
Background: To understand the role of sporadic mutations in the tumor suppressor gene p53 (also known as TP53) in the pathogenesis of breast cancer, it is important to identify at which histologic stage such mutations first occur. We previously showed that a p53 mutation present in invasive breast cancer was found in all surrounding areas of ductal carcinoma in situ (DCIS) but not in areas of hyperplasia or normal breast epithelium. In the present investigation, we studied patients with DCIS, but without invasive breast cancer, to determine the spectrum of DCIS types that can harbor a p53 mutation. Methods: Formalin-fixed, paraffin-embedded tissues from 94 patients with DCIS were evaluated histologically for the predominant cellular architectural pattern, degree of necrosis, and nuclear grade. Each specimen was also assigned an overall histologic grade (with the use of the Van Nuys Prognostic Index pathologic classification). Tissue specimens were stained immunohistochemically with an anti-p53 antibody. Positively stained tissue areas were analyzed for the presence of p53 mutations by single-strand conformation polymorphism and direct sequencing. All statistical tests were two-sided. Results: DCIS from 10 of 94 patients were found to contain p53 missense mutations. All 10 were of a solid or a comedo histologic pattern and contained cells of nuclear grade 2 or 3 (i.e., more abnormal nuclei). The frequency of p53 missense mutations was statistically significantly different among the three overall histologic grade categories (zero [0%] of 49 with low-grade DCIS, one [4.35%] of 23 with intermediate-grade DCIS, and nine [40.9%] of 22 with high-grade DCIS; df = 2 and P<.0001). Conclusion: The DCIS types in patients in this series are representative of clinically detected DCIS. Our finding that p53 mutations can occur before the development of invasive breast cancer, particularly in DCIS of high histologic grade, has potentially important implications for prevention and treatment.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Vincent-Salomon and O. Delattre Role of Genetic, Genomic, and Transcriptomic Factors Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 97 - 103. [Full Text] [PDF]
|
|
|
|
 |
|
 S Aulmann, J Schleibaum, R Penzel, P Schirmacher, G Gebauer, and H P Sinn Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status J. Clin. Pathol., September 1, 2008; 61(9): 1034 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vincent-Salomon, C. Lucchesi, N. Gruel, V. Raynal, G. Pierron, R. Goudefroye, F. Reyal, F. Radvanyi, R. Salmon, J.-P. Thiery, et al. Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast Clin. Cancer Res., April 1, 2008; 14(7): 1956 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, C. R. Pickering, C. R. Holst, M. L. Gauthier, and T. D. Tlsty p16INK4a Modulates p53 in Primary Human Mammary Epithelial Cells Cancer Res., November 1, 2006; 66(21): 10325 - 10331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Rohan, S.-Q. Li, R. Hartwick, and R. A. Kandel p53 Alterations and Protein Accumulation in Benign Breast Tissue and Breast Cancer Risk: A Cohort Study. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1316 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Faedo, C. E. Ford, R. Mehta, K. Blazek, and W. D. Rawlinson Mouse Mammary Tumor-Like Virus Is Associated with p53 Nuclear Accumulation and Progesterone Receptor Positivity but not Estrogen Positivity in Human Female Breast Cancer Clin. Cancer Res., July 1, 2004; 10(13): 4417 - 4419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Freudenheim, M. Bonner, S. Krishnan, C. B. Ambrosone, S. Graham, S. E. McCann, K. B. Moysich, E. Bowman, T. Nemoto, and P. G. Shields Diet and alcohol consumption in relation to p53 mutations in breast tumors Carcinogenesis, June 1, 2004; 25(6): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Simpson, D. L. Page, and M. E. Edgerton p53 in Mammary Ductal Carcinoma In Situ, Mutations in High-Grade Lesions Only? J Natl Cancer Inst, May 2, 2001; 93(9): 666 - 667. [Full Text] [PDF]
|
|